发明名称 |
SINGLE-DOSE ADMINISTRATION OF FACTOR VIIa |
摘要 |
The present invention provides methods for preventing and/or treating bleeding episodes by administering a single dose of a Factor VIIa equivalent. Preferably, the single dose comprises between about 150 and about 500 ug/kg Factor VIIa equivalent. |
申请公布号 |
US2017106060(A1) |
申请公布日期 |
2017.04.20 |
申请号 |
US201615249598 |
申请日期 |
2016.08.29 |
申请人 |
Novo Nordisk HealthCare AG |
发明人 |
Hedner Ulla |
分类号 |
A61K38/48;A61K45/06;A61K9/00 |
主分类号 |
A61K38/48 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating a bleeding episode in a subject in need of such treatment, said method comprising administering intravenously to said subject a Factor VIIa equivalent, wherein said administering is in a single dose and said dose comprises a single-dose-effective amount of said Factor VIIa equivalent and wherein, subsequent to said administration, no further Factor VIIa equivalent is administered to said subject for a period of at least 4 hours. |
地址 |
Zurich CH |